semaglutide and cardiovascular outcomes in obesity without diabetes SELECT Trial Semaglutide and Cardiovascular Outcomes in

Insulin Resistance Insulin resistance, common in conditions like PCOS, can disrupt ovulation and reduce fertility

Additionally, the sensation of fullness and bloating commonly reported with GLP-1 therapy may be misinterpreted as or coexist with reflux symptoms

Kottorp A

GLP-1 injections, such as semaglutide (Ozempic) or tirzepatide (Mounjarno or Zepbound), are administered just under the skintypically in areas like the abdomen, thigh, or upper arm

Ozempic and insulin are both medications used in the management of diabetes , but they function in fundamentally different ways and are used for different aspects of diabetes control